Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0000947871-21-001150

Director bought 5,357,143 shares at $3.50 ($18,750,001)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ORBIMED ADVISORS LLC Director 2021-11-04 Purchase +1,785,715 $3.50 $6,250,003 14,500,119 I
ORBIMED ADVISORS LLC Director 2021-11-04 Purchase +3,571,428 $3.50 $12,499,998 3,571,428 I
Open-market purchases · 5,357,143 sh · avg $3.50 · $18,750,001
Loading xslF345X03/ownership.xml…